Related references
Note: Only part of the references are listed.Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
Aaron J. Tande et al.
CLINICAL INFECTIOUS DISEASES (2022)
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Annette B. Vogel et al.
NATURE (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton et al.
CLINICAL INFECTIOUS DISEASES (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
Shmuel Benenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
Jocelyn Keehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021
Richard A. Teran et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Syncytia formation by SARS-CoV-2-infected cells
Julian Buchrieser et al.
EMBO JOURNAL (2020)
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations
Ludivine Grzelak et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)